CCTG MA.39
Breast Cancer
CCTG MA.39: Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer.
Key Team Members
Principal Investigator
Research Coordinator
Katharine "Kate" Madden
Breast Cancer
CCTG MA.39: Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer.
Katharine "Kate" Madden

